Tag

Pharmaceutical Industry

All articles tagged with #pharmaceutical industry

Lilly bets $4B on infectious-disease push with three acquisitions
business18 hours ago

Lilly bets $4B on infectious-disease push with three acquisitions

Eli Lilly said it will buy Curevo, LimmaTech Biologics and The Vaccine Company for almost $4 billion in cash to expand infectious-disease R&D, sending its shares higher in premarket trading. Curevo develops a shingles vaccine, LimmaTech targets resistant bacterial pathogens including STIs, and The Vaccine Company advances in vivo nanoparticle delivery technologies for drugs, genes, and diagnostics. The move comes as Lilly relies on Zepbound and Mounjaro for strong revenue and introduces Foundayo to compete with Novo Nordisk in obesity treatments.

Trump’s Drug-Pricing Push Delivers Some Discounts, But Prices Climb for Many
healthcare19 days ago

Trump’s Drug-Pricing Push Delivers Some Discounts, But Prices Climb for Many

Trump’s drug-pricing efforts have yielded uneven gains: Medicare's negotiated discounts cut some prices and cap out-of-pocket costs, and TrumpRx offered notable cuts on certain brand drugs, but overall about 1,000 branded drugs rose in price in early 2026, and benefits mostly reach cash-paying patients, with many discounts opaque and limited in scope; experts say the policy changes do not broadly reshape drug pricing.

Big Pharma to Raise Prices on 350 Medications Despite Political Pressure
business4 months ago

Big Pharma to Raise Prices on 350 Medications Despite Political Pressure

Drugmakers plan to raise prices on at least 350 medicines in the US for 2026, including vaccines and cancer treatments, despite pressure from the Trump administration to lower costs. While some drugs will see price cuts, overall prices are increasing, with companies like Pfizer and GSK citing the need to support innovation and cover costs. These hikes occur even as the US continues to pay significantly more for prescription drugs compared to other developed nations.

FDA Grants First Priority Review Vouchers to Nine Drugs
health7 months ago

FDA Grants First Priority Review Vouchers to Nine Drugs

The FDA announced the first nine recipients of the Commissioner’s National Priority Review vouchers, which expedite drug reviews for products aligned with national health priorities. Notably, EMD Serono received a voucher after agreeing to lower prices for its fertility drugs, including Pergoveris, in a move highlighted by President Trump. The program aims to incentivize companies to develop and provide access to important medications.

U.S. Imposes Tariffs on Drugs, Furniture, and Lumber Amid Trade Tensions
business7 months ago

U.S. Imposes Tariffs on Drugs, Furniture, and Lumber Amid Trade Tensions

Drug stocks are rallying as President Trump's proposed 100% tariff on branded pharmaceutical imports mainly affects companies without U.S. manufacturing, leaving most Big Pharma and generics unaffected. The tariffs highlight supply chain vulnerabilities and long-term national security concerns, especially dependence on foreign countries like China for generics, but could also hinder biotech innovation and complicate import processes.

Trump's Drug Pricing Initiatives and Pfizer Deal Spark Industry Shift
business7 months ago

Trump's Drug Pricing Initiatives and Pfizer Deal Spark Industry Shift

Pfizer's surprise deal with the Trump administration on drug pricing, including measures like not launching new drugs at higher U.S. prices than in other wealthy countries and selling drugs at discounted rates, has caught other pharmaceutical companies off guard and increased pressure for similar agreements, potentially influencing future drug pricing and industry dynamics.